TY  - JOUR 
AU  - Riveira Martín, Mercedes
AU  - Struelens, Lara
AU  - Muñoz Iglesias, José
AU  - Schoonjans, Werner
AU  - Tabuenca Dopico, Olga
AU  - Nogueiras Alonso, José Manuel
AU  - Salvador Gómez, Francisco Javier
AU  - López Medina, Antonio
PY  - 2023
SN  - 2197-7364
UR  - http://hdl.handle.net/20.500.11940/18321
AB  - [EN] Background: The use of lutetium-177 (177Lu)-based radiopharmaceuticals in peptide receptor nuclear therapy is increasing, but so is the number of nuclear medicine workers exposed to higher levels of radiation. In recent years, [177Lu]Lu-DOTA-TATE...
LA  - eng
KW  - Radiopharmaceuticals
KW  - Lutetium
KW  - Nuclear Medicine
KW  - Radiation
TI  - Radiation exposure assessment of nuclear medicine staff administering [177Lu]Lu-DOTA-TATE with active and passive dosimetry.
DO  - 10.1186/s40658-023-00592-1
T2  - EJNMMI physics
M2  - 70
KW  - IISGS
KW  - CHUVI
KW  - GALARIA
VL  - 10
ER  -